TMS Therapy for Anxiety and Depression in Boca Raton, FL

Clasped hands on a counselling sofa with a clinician's hands in the background

TMS (transcranial magnetic stimulation) can be used to treat anxiety and depression together in adults whose depression has not improved enough on antidepressants. In August 2021 the FDA cleared the BrainsWay Deep TMS system for decreasing anxiety symptoms in adults with major depressive disorder who have comorbid anxiety, and TMS devices in general have been cleared for depression since 2008. According to the American Psychiatric Association, about one in two people treated with TMS for depression responds and about one in three reaches remission.

This page covers the combined condition, anxious depression: what it is, what the evidence and the FDA clearance actually say, what a course of TMS involves in Boca Raton, who qualifies and how insurance treats it. If your main problem is anxiety without a depressive episode, see the guide to anxiety treatment options and where TMS fits. For TMS in depression generally, see TMS therapy explained for depression.

When Depression and Anxiety Arrive Together

Many people have felt sad and many have felt anxious. The clinical versions are different: persistent, impairing and tied to disruptions in brain circuitry. When both occur together the result is not simply additive. The low energy and hopelessness of depression combine with the hypervigilance, physical tension and dread of anxiety, and patients often describe feeling numb and terrified at once, unable to act and unable to rest. Estimates of how many people with major depressive disorder also have significant anxiety commonly fall between 40 and 60 percent, depending on how anxiety is defined and measured.

Psychiatrists call this pattern major depressive disorder with anxious distress, a specifier in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). It applies when a person in a depressive episode also has at least two of the following on most days: feeling keyed up or tense; feeling unusually restless; difficulty concentrating because of worry; fear that something awful may happen; or a sense of losing control. The specifier matters because it is associated with longer episodes, lower rates of remission on medication alone and a higher risk of suicidal thinking. It is the harder version of an already difficult condition, and it deserves a treatment plan built with it in mind.

Why Anxious Depression Is Harder to Treat Than Depression Alone

The pharmacological problem is concrete. Several drugs that lift depressive symptoms, including older tricyclics and stimulant-type add-ons, can worsen anxiety. SSRIs and SNRIs are the usual first-line choice for anxious depression, but their activation effects in the first two to four weeks can temporarily raise anxiety, and many patients stop before the medication has had a fair trial. When first-line medication fails, the default is to add something: a benzodiazepine for short-term anxiety relief, an atypical antipsychotic, or a second antidepressant. Each addition brings its own side effects and interaction questions.

  • Weight gain, sexual dysfunction, sedation or emotional blunting are hard to live with for people who work in demanding jobs or are active in retirement
  • Benzodiazepines carry addiction risk and are a poor fit for anyone with a history of substance use disorder
  • The SSRI activation period can be intolerable when severe anxiety is already part of the picture
  • Several medications at once make dose changes and drug interactions harder to manage
  • Some antidepressants do not combine safely with drugs older patients already take for heart disease, thyroid conditions or diabetes

Patients who reach this point usually have two realistic next steps: change the medication plan again, or add a non-drug treatment such as TMS. Ketamine-based treatment is another option some clinics offer; the guide to TMS compared with ketamine infusions sets out how the two differ.

How TMS Therapy Works on Anxiety and Depression

TMS uses an electromagnetic coil held against the scalp to deliver brief magnetic pulses to a chosen region of the brain. The pulses pass painlessly through the skull and induce small electrical currents in nearby neurons. Because the treatment acts on brain tissue directly instead of circulating in the bloodstream, it does not affect the liver, kidneys, digestion, hormones, sexual function or body weight the way many medications can.

The usual target in TMS for depression is the left dorsolateral prefrontal cortex, a region that tends to be underactive in major depression and that is involved in executive function and emotional regulation. This region is connected to deeper limbic structures, including the amygdala, the brain's threat-detection center. Chronic anxiety is partly a problem of an overactive threat response, and stimulating the prefrontal cortex is thought to strengthen its regulating influence over those circuits. That is the working explanation for why a treatment aimed at depression may also reduce anxiety symptoms; the clinical evidence for it is covered in the next section.

Standard Coils and the H1 Deep TMS Coil

Standard figure-8 coils stimulate a relatively focused area near the surface. The H1 coil used in BrainsWay Deep TMS is designed to reach a broader and deeper volume of tissue. This is the device behind the 2021 anxiety-related indication. If you are comparing providers, ask which system the clinic uses, which coil it uses for your protocol and what that device's labeling says. Devices are not interchangeable, and their evidence bases differ.

Does TMS Work for Depression and Anxiety? What the Evidence and the FDA Clearance Say

What the 2021 FDA clearance covers

TMS received its first FDA clearance for major depressive disorder in 2008. On August 17, 2021 the FDA cleared an expanded indication for the BrainsWay Deep TMS System (510(k) K210201). According to the FDA decision letter and 510(k) summary, the system is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms in adults with major depressive disorder who may have comorbid anxiety and who did not achieve satisfactory improvement from antidepressant medication in the current episode (FDA 510(k) K210201).

Two details in that wording are worth knowing. First, the indication is for decreasing anxiety symptoms in people who have depression, not for anxiety disorders on their own. Second, it was a 510(k) clearance: the FDA found the modified device substantially equivalent to earlier BrainsWay devices, and the new indication rested on an analysis of existing studies rather than on one new trial recruiting only people with anxious depression.

How strong is the anxiety evidence?

The FDA summary describes the supporting data as three randomized controlled trials plus meta-analyses of 11 studies (the three trials and eight open-label studies) covering 573 patients. Anxiety was measured with the anxiety-somatization factor of the 21-item Hamilton Depression Rating Scale, a subscale of a depression scale, not a stand-alone anxiety questionnaire. In the two sham-controlled trials the between-group effect sizes were 0.34 and 0.36; in the third trial, which compared Deep TMS with standard medication care, it was 0.905. The pooled effect size across the three trials was 0.55, which the summary calls a medium effect.

In plain terms, the trials found that anxiety symptoms improved more with Deep TMS than with sham stimulation or medication-only care, by a moderate margin on average. Individual results vary, and a medium group effect does not guarantee relief for any one person. For depression itself, the APA reports that about one in two patients responds and about one in three remits (American Psychiatric Association, What is TMS).

Reading TMS reviews

Searches for "TMS for depression and anxiety reviews" mix two very different things. Patient reviews on clinic and listing sites describe individual experiences, cannot be checked for diagnosis or protocol, and tend to come from people with strong feelings either way. Trial data and meta-analyses describe groups under controlled conditions. Use patient reviews to learn what the experience is like (scheduling, comfort, staff communication) and the trial data to judge how likely benefit is. A useful review names the device, the number of sessions and the symptom scale used; a review that says only "it changed my life" or "it did nothing" tells you little about whether the treatment fits your situation.

What a Full TMS Course Looks Like in Boca Raton

A standard course is five sessions a week for four to six weeks, according to the National Institute of Mental Health and the APA, with sessions lasting from a few minutes to about 40 minutes depending on the device and protocol. Many protocols total 36 sessions, which stretches treatment to roughly six to nine weeks; the sham-controlled Deep TMS trials in the FDA summary ran about four weeks. Shorter accelerated protocols such as SAINT use several sessions a day and can finish in about five days (APA). No sedation or recovery time is needed, and most patients drive themselves and return to normal activities (NIMH, Brain Stimulation Therapies).

  1. Evaluation and motor threshold measurement: A psychiatric provider reviews your history, prior treatments and contraindications, and records baseline symptom scores. Before treatment starts, the clinician finds your motor threshold, the lowest magnetic field strength that produces a visible thumb twitch. Scalp-to-cortex distance varies between people, so this calibration tunes the dose to your anatomy.
  2. First sessions: Early sessions focus on precise coil placement and getting used to the sensation, usually described as rhythmic tapping on the scalp. Mild scalp discomfort or a tension-type headache is common at first and usually eases.
  3. Mid-course: Standardized rating scales are repeated through the course. Some patients report changes in the middle weeks, such as less background worry, better sleep or moments of calm, but the timing is individual, and improvement in depression and anxiety does not always move in step.
  4. Final sessions: The team reviews the scale scores together with how you feel and decides whether to continue, adjust the protocol or conclude.
  5. Follow-up: A responsible clinic discusses what happens after the last session, including whether maintenance sessions are appropriate and how TMS fits with your therapist or prescriber. See how long TMS results last and when retreatment is considered.

A daily weekday schedule is easier to keep when the clinic is close to home or work, which is one practical reason people in Boca Raton and southern Palm Beach and Broward counties look for local providers rather than traveling to Miami or Fort Lauderdale.

Who Is a Candidate for TMS With Anxious Depression

A psychiatric evaluation decides eligibility. These profiles are most often considered:

  • Depression that has not responded adequately to at least one antidepressant. This is the standard clearance and insurance threshold: the NIMH describes the FDA clearance as covering depression that did not respond to at least one antidepressant in the current episode. The APA notes that many insurers cover standard TMS after three to four failed antidepressant trials. See also TMS for treatment-resistant depression.
  • People who cannot tolerate antidepressant side effects such as weight gain, sexual dysfunction, emotional blunting or sedation, and have stopped medication despite some benefit.
  • People who cannot safely take more medication because of other health conditions or interaction risks. TMS is not a drug and does not circulate in the bloodstream, so it adds no drug interactions.
  • People who are pregnant or planning pregnancy. Antidepressant use in pregnancy involves a real risk-benefit discussion. Whether TMS is appropriate needs individual assessment by your OB-GYN and the TMS provider.
  • People with a history of substance use disorder for whom a benzodiazepine would be inappropriate. TMS is not a controlled substance and is not addictive in the way benzodiazepines can be.
  • People who prefer a time-limited, non-drug treatment. This is a legitimate preference, and it is usually combined with continuing medication and therapy rather than replacing them.

Who it does not suit: the APA lists metal implants in the head, aneurysm clips or coils, cochlear implants, cardiac defibrillators and a history of epilepsy as reasons a person generally would not be a candidate. The Deep TMS clearance applies to adults. The FDA cleared adjunctive rTMS for adolescents aged 15 and older in March 2024 (NIMH); for younger patients see the guide to TMS therapy for teens and adolescents.

Side Effects and What to Expect

TMS is generally well tolerated and has a milder side-effect profile than systemic psychiatric medication, but it is not free of side effects. When anxiety is part of the picture, knowing what is normal helps, because unexpected sensations can otherwise become a new source of worry.

  • Scalp discomfort and tapping sensation at the coil site, usually mild to moderate and often easier after the first week or two.
  • Facial or scalp muscle twitching and tingling while the coil is firing, which stops when stimulation stops.
  • Mild headaches and brief lightheadedness, which usually respond to over-the-counter pain relievers and become less frequent as treatment continues.
  • Uncommon effects: the APA lists severe headache, fainting and hearing loss (prevented with earplugs). Seizure is rare, at about 1 in 10,000 according to the APA, and the NIMH describes the risk as low when expert guidelines are followed.

For more detail, including what to report to the clinic and how safety screening works, see TMS side effects and safety. Patients who notice no change in the first two weeks should not conclude the treatment is failing, because improvement is gradual. If a full course brings no change, a responsible provider reviews the diagnosis, coil position and stimulation parameters before deciding whether to change the protocol or try another approach.

Insurance and Cost for TMS in Florida

Large commercial insurers operating in Florida, including Florida Blue, Aetna, UnitedHealthcare, Cigna and Humana, have published medical policies that cover TMS for major depressive disorder when their clinical criteria are met. Those criteria typically include documented failure of one or more medication trials, and they differ between plans and can change from one plan year to the next.

Medicare does not set TMS coverage in a single national rule. Coverage is set regionally through local coverage determinations (LCDs) issued by each Medicare Administrative Contractor. As one example, Novitas Solutions' LCD L34998 covers TMS for severe major depressive disorder after one or more failed medication trials or intolerance to medication, with the order written by a psychiatrist and daily treatment for up to six weeks. That LCD applies to Novitas's own jurisdictions; the contractor that serves Florida publishes its own policy, so ask the clinic which one applies to you (source: Medicare Coverage Database, LCD L34998). Medicaid coverage varies by managed care plan.

Coverage for the anxious-depression presentation usually depends on how the diagnosis is documented. A plan will generally review the major depressive disorder diagnosis, prior treatments and severity, not the anxiety specifier by itself. Ask for a written benefits verification before the first session, and if you are paying yourself, request a written estimate and ask about payment plans. For fees, prior authorization and what to ask your insurer, see the guide to TMS cost and insurance coverage.

Choosing a TMS Provider for Anxious Depression

Because anxious depression is harder to treat, a few questions matter more than usual:

  • Which device and coil does the clinic use, and what does its labeling say? Ask whether it carries the anxiety-related indication or only the general depression clearance.
  • Who supervises treatment? A psychiatrist or other licensed psychiatric prescriber should oversee the course, not only a technician operating the machine.
  • Is there a full evaluation first? Psychiatric history, prior treatment review, contraindication screening and baseline symptom scores should come before the first session.
  • What happens if you are not improving mid-course? A good clinic can explain how it reassesses and adjusts.
  • Does the clinic coordinate with your therapist, prescriber and primary care doctor? TMS works best as part of a wider plan.

The guide on how to choose a TMS provider in Boca Raton covers credentials, equipment and consultation questions in full.

Frequently Asked Questions

Does TMS work for depression and anxiety together?

For many people it helps, though not for everyone. The FDA's 2021 clearance of the BrainsWay Deep TMS system rested on three randomized trials and supporting studies that found a medium pooled effect (0.55) on anxiety symptoms in adults with major depressive disorder. The APA reports that about half of patients treated with TMS for depression respond and about a third reach remission. A minority get little benefit, so the outcome should be judged against scores measured before and during the course.

What exactly is anxious depression, and is it a real diagnosis?

Yes. The DSM-5 recognizes it as major depressive disorder with the anxious distress specifier, applied when a depressive episode comes with at least two features such as feeling keyed up, restless, unable to concentrate because of worry, or afraid that something awful will happen. It is common, and it is linked to longer episodes and lower remission rates on medication alone.

Is TMS FDA-cleared for anxious depression or only for depression?

Both. TMS has been cleared for major depressive disorder since 2008. In August 2021 the FDA cleared an expanded indication for the BrainsWay Deep TMS system covering depressive episodes and decreasing anxiety symptoms in adults with major depressive disorder who did not improve on antidepressants. The clearance is for anxiety symptoms in people with depression, not for anxiety disorders alone. Ask your clinic which device it uses.

Is TMS used for anxiety alone?

The cleared indication above is tied to depression. TMS for anxiety disorders without depression is a separate question with its own evidence, covered on the anxiety page linked in the introduction above.

How many sessions will I need, and how long does a course take?

The NIMH and APA describe a standard course as five days a week for four to six weeks. Many protocols total 36 sessions over about six to nine weeks. Sessions run from a few minutes to about 40 minutes depending on the device. Accelerated protocols can finish in about five days, though the conventional daily format has the longest track record.

Will TMS make my anxiety worse before it gets better?

TMS is not a drug and is not known for the early activation phase that can briefly raise anxiety with SSRIs. It does have its own early-session discomfort, and some people feel nervous about the procedure itself, so tell the clinic about any notable change instead of interpreting it alone.

Can I stop my antidepressant if TMS works?

Decide this with your prescriber, not on your own. TMS is usually used alongside existing medication, and stopping an antidepressant abruptly risks discontinuation symptoms and relapse even when you feel well. If you reach remission, a gradual taper supervised by your prescriber may be possible.

Does insurance cover TMS for anxious depression in Florida?

Many commercial plans and Medicare cover TMS for major depressive disorder when documented criteria are met, usually including at least one prior medication trial without enough benefit. Coverage depends on your plan and, for Medicare, on the regional contractor's policy. Ask the clinic to run a formal benefits verification with your insurance details before you start.

If you are living with persistent low mood and chronic worry and standard treatments have not given you enough relief, a consultation with a licensed psychiatrist or other qualified clinician is a practical next step. Useful questions for a first appointment: whether TMS suits your clinical situation, which device and protocol the provider would use, and what your insurance is likely to cover.

Keep reading

This guide offers general information, not medical advice. Always talk to a licensed professional about your own situation.

Read the TMS guide